Cargando…
Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices
BACKGROUND: The extent to which MS patients with cognitive dysfunction can accurately self-report outcomes has been a crucial issue. The aim of this study was to quantify and compare the relevance of the quality of life (QoL) assessment between two populations with a high occurrence of cognitive dys...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984183/ https://www.ncbi.nlm.nih.gov/pubmed/24708665 http://dx.doi.org/10.1186/1471-2377-14-78 |
_version_ | 1782311414690480128 |
---|---|
author | Baumstarck, Karine Boucekine, Mohamed Boyer, Laurent Aghababian, Valérie Parola, Nathalie Reuter, Françoise Loundou, Anderson Lançon, Christophe Pelletier, Jean Auquier, Pascal |
author_facet | Baumstarck, Karine Boucekine, Mohamed Boyer, Laurent Aghababian, Valérie Parola, Nathalie Reuter, Françoise Loundou, Anderson Lançon, Christophe Pelletier, Jean Auquier, Pascal |
author_sort | Baumstarck, Karine |
collection | PubMed |
description | BACKGROUND: The extent to which MS patients with cognitive dysfunction can accurately self-report outcomes has been a crucial issue. The aim of this study was to quantify and compare the relevance of the quality of life (QoL) assessment between two populations with a high occurrence of cognitive dysfunction, specifically in individuals with multiple sclerosis (MS) and in individuals suffering from schizophrenia (SCZ). METHODS: Design: A cross-sectional study was performed using the following inclusion criteria: MS and SCZ patients were diagnosed according to the McDonald criteria and DSM-IV criteria, respectively. Data on sociodemographic (age, gender, education level) and clinical (disease severity, disease duration) factors, QoL (disease-specific questionnaires, MusiQoL and SQoL) and cognitive performance (executive, memory, and attention functions) were collected. Non-impaired and impaired populations were defined according to the French norms. Psychometric properties were compared to those reported in reference populations, which were assessed in the respective validation studies. Suitability indices were provided used to quantitatively compare how the structures in the different populations matched with the initial structure of the questionnaires (reference populations). RESULTS: One hundred and twenty-four MS patients and 113 SCZ patients were enrolled. Factor analysis was performed on the impaired populations and revealed that the questionnaire structure adequately matched the initial structure of the disease-specific QoL questionnaires. All of the suitability indices of construct and external validity in the non-impaired populations ranged from 70 to 100%. CONCLUSIONS: Our study suggested that cognitive dysfunction did not compromise the reliability or validity of the self-reported QoL questionnaires among subjects with cognitive dysfunction, such as MS and SCZ. Thus, this report may clarify the relevance of using self-reported QoL assessments in clinical practice. |
format | Online Article Text |
id | pubmed-3984183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39841832014-04-12 Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices Baumstarck, Karine Boucekine, Mohamed Boyer, Laurent Aghababian, Valérie Parola, Nathalie Reuter, Françoise Loundou, Anderson Lançon, Christophe Pelletier, Jean Auquier, Pascal BMC Neurol Research Article BACKGROUND: The extent to which MS patients with cognitive dysfunction can accurately self-report outcomes has been a crucial issue. The aim of this study was to quantify and compare the relevance of the quality of life (QoL) assessment between two populations with a high occurrence of cognitive dysfunction, specifically in individuals with multiple sclerosis (MS) and in individuals suffering from schizophrenia (SCZ). METHODS: Design: A cross-sectional study was performed using the following inclusion criteria: MS and SCZ patients were diagnosed according to the McDonald criteria and DSM-IV criteria, respectively. Data on sociodemographic (age, gender, education level) and clinical (disease severity, disease duration) factors, QoL (disease-specific questionnaires, MusiQoL and SQoL) and cognitive performance (executive, memory, and attention functions) were collected. Non-impaired and impaired populations were defined according to the French norms. Psychometric properties were compared to those reported in reference populations, which were assessed in the respective validation studies. Suitability indices were provided used to quantitatively compare how the structures in the different populations matched with the initial structure of the questionnaires (reference populations). RESULTS: One hundred and twenty-four MS patients and 113 SCZ patients were enrolled. Factor analysis was performed on the impaired populations and revealed that the questionnaire structure adequately matched the initial structure of the disease-specific QoL questionnaires. All of the suitability indices of construct and external validity in the non-impaired populations ranged from 70 to 100%. CONCLUSIONS: Our study suggested that cognitive dysfunction did not compromise the reliability or validity of the self-reported QoL questionnaires among subjects with cognitive dysfunction, such as MS and SCZ. Thus, this report may clarify the relevance of using self-reported QoL assessments in clinical practice. BioMed Central 2014-04-08 /pmc/articles/PMC3984183/ /pubmed/24708665 http://dx.doi.org/10.1186/1471-2377-14-78 Text en Copyright © 2014 Baumstarck et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Baumstarck, Karine Boucekine, Mohamed Boyer, Laurent Aghababian, Valérie Parola, Nathalie Reuter, Françoise Loundou, Anderson Lançon, Christophe Pelletier, Jean Auquier, Pascal Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices |
title | Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices |
title_full | Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices |
title_fullStr | Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices |
title_full_unstemmed | Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices |
title_short | Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices |
title_sort | quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984183/ https://www.ncbi.nlm.nih.gov/pubmed/24708665 http://dx.doi.org/10.1186/1471-2377-14-78 |
work_keys_str_mv | AT baumstarckkarine quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT boucekinemohamed quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT boyerlaurent quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT aghababianvalerie quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT parolanathalie quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT reuterfrancoise quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT loundouanderson quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT lanconchristophe quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT pelletierjean quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices AT auquierpascal quantificationofrelevanceofqualityoflifeassessmentforpatientswithcognitiveimpairmentthesuitabilityindices |